Main menu

Characterising the complete transcriptome and proteome with GenomeProt | LC26

  • Published on:

Abstract
Identifying the RNAs and proteins produced by cells is fundamental to the biological and clinical sciences. However, many RNAs remain uncharacterised and the proteins they encode unknown, especially proteins translated from alternate RNA isoforms: untranslated regions (UTRs) and non-coding RNAs. A promising method to overcome these restrictions is proteogenomics, which combines a sample-specific database of open reading frames based on RNA-seq with mass spectrometry. However, current proteogenomic tools have limitations in usability, analysis features, and none can analyse single-cell data. Here, we introduce GenomeProt, a user-friendly proteogenomics web server that takes in long-read RNA sequencing and mass spectrometry data and outputs gene, isoform, and protein expression, combined with intuitive visualisation and analysis features. We demonstrate GenomeProt on cell culture models of bone, cortical brain organoids, in vivo human brain and during development of therapy resistance in cancer. In human brain we identified translation of >8,000 RNA isoforms, 5,500 known proteins, and >350 novel proteins, including translation of alternate isoforms, UTRs, pseudogenes, and non-coding RNAs such as DLX6-AS1. In cancer, we track changes in the transcriptome and proteome as therapy resistance develops, including the impact of genome mutations. Applying GenomeProt’s unique single-cell analysis mode to brain organoids, we identified >20,000 cell-type marker RNAs and their known and novel translated products; for example, we discovered ZC2HC1A, a gene of unknown function, is a marker of a unique and transient population of early neurons. GenomeProt puts the power of proteogenomics into the hands of biologists, enabling unprecedented characterisation of genome outputs, regulation, and cellular function during development and disease.

Biography
Dr Mike Clark is a group leader at The University of Melbourne in Australia. His research sits at the intersection of genomics and neuroscience, developing and utilizing long-read transcriptomic approaches to investigate gene expression and function in the human brain and in neuropsychiatric disorders. Mike is particularly interested in the role of RNA isoforms in development and disease, including how they contribute to pathogenicity in both rare and complex conditions.

Authors: Mike Clark

Getting started

Buy a MinION starter pack Nanopore store Sequencing Service providers Channel Partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditation
Spanish flag